Agonist News and Research

RSS
Researchers find link between chronic inflammation and cancer

Researchers find link between chronic inflammation and cancer

Watson to launch ella emergency contraceptive in fourth-quarter 2010

Watson to launch ella emergency contraceptive in fourth-quarter 2010

FDA approves ellaOne for emergency contraception

FDA approves ellaOne for emergency contraception

New findings identify mGlu2/3 receptors as a promising treatment target for cocaine addicts

New findings identify mGlu2/3 receptors as a promising treatment target for cocaine addicts

Clinical Data first-quarter gross revenue increases 52% to $6.2 million

Clinical Data first-quarter gross revenue increases 52% to $6.2 million

GTx second-quarter net loss increases to $12.9 million

GTx second-quarter net loss increases to $12.9 million

TEMPO study recommends early administration of Azilect in PD patients

TEMPO study recommends early administration of Azilect in PD patients

Shire proposes acquisition of Movetis for fully diluted equity purchase price of EUR428 million

Shire proposes acquisition of Movetis for fully diluted equity purchase price of EUR428 million

Targacept licenses Cornerstone technology for inflammatory disorders program

Targacept licenses Cornerstone technology for inflammatory disorders program

Idera announces $15 million registered direct offering

Idera announces $15 million registered direct offering

Chemical compound provides new angle for developing drugs to treat seizures: Study

Chemical compound provides new angle for developing drugs to treat seizures: Study

Adolor second-quarter net loss decreases to $8.3 million

Adolor second-quarter net loss decreases to $8.3 million

Intercept signs CRADA with NIDDK for study of obeticholic acid in nonalcoholic steatohepatitis

Intercept signs CRADA with NIDDK for study of obeticholic acid in nonalcoholic steatohepatitis

Need for better understanding of appropriate treatment choices for children with insomnia: Study

Need for better understanding of appropriate treatment choices for children with insomnia: Study

Teva second-quarter net sales increase 12% to $3.8 billion

Teva second-quarter net sales increase 12% to $3.8 billion

NIH issues SBIR grant to Titan Pharmaceutical for PD treatment development

NIH issues SBIR grant to Titan Pharmaceutical for PD treatment development

Seaside Therapeutics reports positive data from STX209 Phase 2 study in fragile X syndrome

Seaside Therapeutics reports positive data from STX209 Phase 2 study in fragile X syndrome

IDC secures $32 million in Series B financing

IDC secures $32 million in Series B financing

New understanding on insulin resistance, action of diabetes drugs may lead to safer medication

New understanding on insulin resistance, action of diabetes drugs may lead to safer medication

Scientists uncover new mechanism that reduces risk of type 2 diabetes, cardiovascular disease

Scientists uncover new mechanism that reduces risk of type 2 diabetes, cardiovascular disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.